Clinical trial
A Phase I，Randomized, Double-blind，Placebo Controlled，Dose Escalated, Single Adminstrated Clinical Trial of PEGIFNα1b in Chinese Healthy Adults
NCT05639803 is registered in ClinicalTrials.gov with Shanghai Institute Of Biological Products as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I，Randomized, Double-blind，Placebo Controlled，Dose Escalated, Single Adminstrated Clinical Trial of PEGIFNα1b in Chinese Healthy Adults
- Lead sponsor
- Shanghai Institute Of Biological Products
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 7, 2020
- Completion date
- October 22, 2020
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.